Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bayer (DE:BAYN)
XETRA:BAYN
Bayer (BAYN) Stock Price & Analysis
502 Followers
BAYN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€24.86 - €53.58
Previous Close€26.21
Volume468.49K
Average Volume (3M)3.34M
Market Cap
€25.74B
Enterprise Value€57.06B
Total Cash (Recent Filing)€10.15B
Total Debt (Recent Filing)€41.32B
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Aug 06, 2024EPS Estimate
€0.97Last Dividend Ex-Date
Apr 29, 2024Dividend Yield0.42%
Share Statistics
EPS (TTM)-3.17
Shares Outstanding982,424,082
10 Day Avg. Volume3,346,238
30 Day Avg. Volume3,335,896
Standard Deviation0.10
R-Squared0.21
Alpha-0.00667
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€30.50Price Target Upside16.68% Upside
Rating ConsensusHold
Number of Analyst Covering12
Bayer News
Bulls Say, Bears Say
Bulls Say
EarningsEBITDA was higher than expected, driven by Crop Science margins and stronger EPS on lower financial costs.
GuidanceManagement reiterated its FY24 guidance at CER.
Litigation And ReorganisationThe company delivered a reassuring message during the conference call with regard to the rest of the year, provided an update regarding favorable decisions related to the PCB litigation and emphasised that its reorganisation effort is well on track.
Bears Say
Legal UncertaintyThe outcome of court rulings regarding glyphosate cases continues to be unpredictable.
Price ImpactCrop Science must still absorb much lower glyphosate prices, with an expected negative price impact of €250m.
Sales Performance1Q sales declined 1% at constant exchange rate and structure, falling short of consensus expectations by 2% due to weaker performance in Crop Science and Consumer Health.
---
Options Prices
Currently, No data available
---
Ownership Overview
<0.01% Insiders
16.97% Mutual Funds
12.12% Other Institutional Investors
70.91% Public Companies and
Individual Investors
BAYN FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was €24.86 and its highest was €53.58 in the past 12 months.
What is Bayer’s market cap?
Currently, no data Available
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Aug 06, 2024 which is in 31 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on May 14, 2024. The company reported €2.82 earnings per share for the quarter, beating the consensus estimate of €2.318 by €0.502.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of €0.11 which represents an annual dividend yield of 0.42%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is €0.97.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of €2.82 in its last earnings report, beating expectations of €2.318. Following the earnings report the stock price went down -0.545%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in DE:BAYN
---
Bayer Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.81%
12-Months-Change
Fundamentals
Return on Equity
-8.16%
Trailing 12-Months
Asset Growth
-4.13%
Trailing 12-Months
Company Description
Bayer
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides just over half of the company's sales and includes pharmaceutical drugs as well as vitamins. The company has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
---
BAYN Stock 12 Month Forecast
Average Price Target
€30.50
▲(16.68% Upside)
Technical Analysis
Best Analysts Covering BAYN
1 Year
1 Year Success Rate
8/26 ratings generated profit
1 Year Average Return
-10.77%
reiterated a buy rating last month
Copying Peter Spengler's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -10.77% per trade.
---